More evidence to support the role of S2 in P50 studies

Schizophrenia Research

Volumn 122, Issue 1-3, 2010, Pages 270-272

  Shan, Jia Chi ^a   Hsieh, Ming H ^b   Liu, Chih Min ^c   Chiu, Ming Jang ^a   Jaw, Fu Shan ^b   Hwu, Hai Gwo ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ACTION POTENTIAL; AUTOMATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTROPHYSIOLOGY; HUMAN; LATENT PERIOD; LETTER; NEUROTRANSMISSION; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORY GATING; SIGNAL NOISE RATIO;

ACOUSTIC STIMULATION; ADULT; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SENSORY GATING; SMOKING;

EID: 77956225833     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.05.026     Document Type: Letter

References (15)

1. Adler L.E., Hoffer L.J., Griffith J., Waldo M.C., Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol. Psychiatry 1992, 32:607-616.
2. Boutros N. Lack of blinding in gating studies. Schizophr. Res. 2008, 103:336. author reply 337.
3. Brockhaus-Dumke A., Schultze-Lutter F., Mueller R., Tendolkar I., Bechdolf A., Pukrop R., Klosterkoetter J., Ruhrmann S. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol. Psychiatry 2008, 64:376-384.
4. Clementz B.A., Geyer M.A., Braff D.L. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr. Res. 1998, 30:71-80.
5. de Wilde O.M., Bour L.J., Dingemans P.M., Koelman J.H.T.M., Linszen D.H. A meta-analysis of P50 studies in patients with schizophrenia and relatives: differences in methodology between research groups. Schizophr. Res. 2007, 97:137-151.
6. de Wilde O., Bour L., Dingemans P., Koelman H., Linszen D. Response to letter: "Lack of blinding in gating studies". Schizophr. Res. 2008, 103:337-337.
7. Fresan A., Apiquian R., Garcia-Anaya M., de la Fuente-Sandoval C., Nicolini H., Graff-Guerrero A. The P50 auditory evoked potential in violent and non-violent patients with schizophrenia. Schizophr. Res. 2007, 97:128-136.
8. Hong X., Chan R.C., Zhuang X., Jiang T., Wan X., Wang J., Xiao B., Zhou H., Jiang L., Weng B. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia. Schizophr. Res. 2009, 108:151-157.
9. Myles-Worsley M. P50 sensory gating in multiplex schizophrenia families from a Pacific island isolate. Am. J. Psychiatry 2002, 159:2007-2012.
10. Nagamoto H.T., Adler L.E., Waldo M.C., Freedman R. Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biol. Psychiatry 1989, 25:549-561.
11. Olincy A., Martin L. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. Am. J. Psychiatry 2005, 162:43-49.
12. Potter D., Summerfelt A., Gold J., Buchanan R.W. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophr. Bull. 2006, 32:692-700.
13. Swerdlow N.R., Geyer M.A., Shoemaker J.M., Light G.A., Braff D.L., Stevens K.E., Sharp R., Breier M., Neary A., Auerbach P.P. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology 2006, 31:506-515.
14. Turetsky B.I., Calkins M.E., Light G.A., Olincy A., Radant A.D., Swerdlow N.R. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr. Bull. 2007, 33:69-94.
15. Yee C.M., Nuechterlein K.H., Morris S.E., White P.M. P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects. J. Abnorm. Psychol. 1998, 107:691-698.